Moderna quarterly report and a weak forecast made the shares of the company drop by almost 18%. Analysts and investors are disappointed. Tech analysis of Moderna shares for 05.11.2021.
All posts
Novavax and Moderna shares have started to fall. The reasons are as follows: Novavax has postponed its application to the FDA, and its quarterly report is weak, while Moderna shares are naturally correcting. Tech analysis of Novavax and Moderna shares.
On July 21st, Moderna will join the S&P 500 index. This news made its shares go up by over 10%. Tech analysis of Moderna shares for July 19th, 2021.
Why are AstraZeneca stocks growing regardless of bad news? The EU stopped using the vaccine fearing possible thrombosis in patients. The terms of production and supply are violate.
Pandemic, quarantine, vaccines, the growth of the IT sector, antitrust litigation of technology corporations, the explosive success of Tesla, and, of course, Brexit - these are our most significant events of the year.
What does the appearance of the new strain mean?
Now those investors who missed the growth of stock prices in summer have to look for something to make money on. The time has come to pay attention to pharmaceutical companies again.
COVID-19. Unofficially, we have a vaccine. Officially, we might have it in May.
Coronavirus keeps threatening the world economy. The S&P500 index is again trading near its recent lows: by the moment this article is published, it will most probably have broken the support level at 2,850 USD and go on declining.